Understanding immune responses to infections like MRSA and Candida.
Official title: Immunomics Research Core
Funded at Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center · NIH-11091665 · Data updated 2026-11-12
This study is looking at how infections from MRSA or Candida albicans affect your immune system and genes, and if you join, we’ll analyze your blood samples to help find better ways to treat these infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center NIH-funded |
| Lab location | 1 site (Torrance, United States) |
| Project start | August 10, 2023 |
| Project end | May 31, 2028 |
| Funding year | 2025 |
| Award (this year) | $358,800 |
| NIH project number | 5U19AI172713-03 |
| Project ID | NIH-11091665 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research are patients diagnosed with infections caused by MRSA or Candida albicans.
✕Less likely to help
Patients with infections caused by other pathogens or those not infected may not receive any benefit from this research.
What this research studies
This research focuses on characterizing the immune responses and epigenetic changes in patients infected with methicillin-resistant Staphylococcus aureus (MRSA) or Candida albicans. By analyzing patient samples, the study aims to understand how these infections affect the immune system and the genetic factors involved. The research employs advanced techniques such as whole genome sequencing and profiling of immune responses to gather comprehensive data that could inform treatment strategies. Patients may have their blood and plasma samples analyzed to uncover insights into their specific immune responses.
Why it matters
Potential benefit: If successful, this research could lead to improved treatment strategies for patients suffering from severe infections, enhancing recovery and reducing antibiotic resistance.
How similar studies have gone: Previous research has shown promise in understanding immune responses to infections, making this approach both relevant and potentially impactful.
Where this research is happening
-
Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
Torrance, United States Active
Researchers
- Principal investigator: Cappelletti, Monica — Lundquist Institute for Biomedical Innovation at Harbor-UCLA Medical Center
- Study coordinator: Cappelletti, Monica
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.